1. Home
  2. BCYC vs APEI Comparison

BCYC vs APEI Comparison

Compare BCYC & APEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • APEI
  • Stock Information
  • Founded
  • BCYC 2009
  • APEI 1991
  • Country
  • BCYC United Kingdom
  • APEI United States
  • Employees
  • BCYC N/A
  • APEI N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • APEI Other Consumer Services
  • Sector
  • BCYC Health Care
  • APEI Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • APEI Nasdaq
  • Market Cap
  • BCYC 492.1M
  • APEI 453.1M
  • IPO Year
  • BCYC 2019
  • APEI 2007
  • Fundamental
  • Price
  • BCYC $6.92
  • APEI $35.96
  • Analyst Decision
  • BCYC Buy
  • APEI Strong Buy
  • Analyst Count
  • BCYC 11
  • APEI 7
  • Target Price
  • BCYC $22.91
  • APEI $35.67
  • AVG Volume (30 Days)
  • BCYC 213.9K
  • APEI 250.9K
  • Earning Date
  • BCYC 10-30-2025
  • APEI 11-03-2025
  • Dividend Yield
  • BCYC N/A
  • APEI N/A
  • EPS Growth
  • BCYC N/A
  • APEI 321.15
  • EPS
  • BCYC N/A
  • APEI 1.05
  • Revenue
  • BCYC $19,281,000.00
  • APEI $644,549,000.00
  • Revenue This Year
  • BCYC N/A
  • APEI $7.21
  • Revenue Next Year
  • BCYC N/A
  • APEI $4.33
  • P/E Ratio
  • BCYC N/A
  • APEI $33.61
  • Revenue Growth
  • BCYC N/A
  • APEI 5.50
  • 52 Week Low
  • BCYC $6.10
  • APEI $13.45
  • 52 Week High
  • BCYC $28.67
  • APEI $36.31
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 41.28
  • APEI 70.79
  • Support Level
  • BCYC $6.77
  • APEI $34.58
  • Resistance Level
  • BCYC $7.32
  • APEI $35.97
  • Average True Range (ATR)
  • BCYC 0.39
  • APEI 1.31
  • MACD
  • BCYC 0.01
  • APEI 0.44
  • Stochastic Oscillator
  • BCYC 19.04
  • APEI 95.18

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About APEI American Public Education Inc.

American Public Education Inc provides online and campus based postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.

Share on Social Networks: